Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Nizar Bahlis
Myeloma immunotherapy
Jianhua Yu
myeloma immunotherapy
Ricky Johnstone
lymphoma and myeloma
Michaela Reagan
Multiple Myeloma
Suzanne Lentzsch
Myeloma
Christopher Flowers
clinical trial access
Jing Fu
myeloma
Carl June
CAR T immunotherapy
Ruben Carrasco
Myeloma
Caroline Arber
myeloma CAR-T
F. Lennie Wong
Equity in Access
Lawrence Boise
CART and myeloma
Tanya Siddiqi
clinical trial access
Simona Colla
Myeloma biology
Madhav Dhodapkar
multiple myeloma immunotherapy
William Matsui
Myeloma
Sigurður Kristinsson
Smoldering myeloma
Alfred Garfall
myeloma immunotherapy
Siegfried Janz
Myeloma immunotherapy
Jun Qi
Myeloma
Eugenio Morelli
Myeloma
Mala Shanmugam
myeloma
Paul Beavis
immunotherapy in myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
John Leonard
lymphoma research
Robert Orlowski
(Smoldering) Multiple Myeloma
Urvi Shah
Diet and myeloma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Noemí Puig Morón
Myeloma
Fenghuang Zhan
Myeloma and bone disease
Jing Yang
Myeloma
Qing Yi
Novel CAR-T
Peter Croucher
Multiple Myeloma
Jonathan Licht
DNA biology, myeloma
Lev Kats
myeloma and epigenetics
Matteo Bellone
Smoldering multiple myeloma
Sham Mailankody
Myeloma immunotherapy clinical trials
Armin Rashidi
gut bacteria and transplant success
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Bruno Paiva
smoldering myeloma
Brian Walker
smoldering myeloma, MGUS